C4 Therapeutics, Inc. · NASDAQ:CCCC
Morgan Stanley reported a 6.70% stake in C4 Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 7, 2025
Morgan Stanley reported a 6.70% stake in C4 Therapeutics, Inc., 4,750,383 shares, as a passive investor on Jun 30, 2025. Filed Aug 7, 2025 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 4,750,383
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.70% | 4,750,383 |
Source
Related
- C4 Therapeutics, Inc.
- Morgan Stanley
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Aug 12, 2026
- Schedule 13G/A · Morgan Stanley · Feb 11, 2026
- Schedule 13G · Morgan Stanley · Feb 3, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026